Azeria Therapeutics
Azeria Therapeutics is the world’s first pioneer factor drug discovery company.
Azeria Therapeutics has raised €36M across 1 funding round from 1 investor, most recently a Series B round in Oct 2019. Based in Cambridge, UK; founded 2013; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€36M
€36,128,391
Funding rounds
1
Investors
1
distinct backers
Active since
2019-10
latest 2019-10
Funding by year
EUR raised per yearAzeria Therapeutics — funding by year — interactive chart.
Data table
| Azeria Therapeutics — funding by year | |
|---|---|
| 2019 | €36M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series B | €36M | Syncona Partners | View deal → |